Protein P (Hepatitis-B-Virus) (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Protein P (Hepatitis-B-Virus)" in German language version.

refsWebsite

Global rank German rank

2^nd place

3^rd place

4^th place

7^th place

123^rd place

6^th place

5,673^rd place

995^th place

doi.org

S. K. Ono-Nita, N. Kato, Y. Shiratori, T. Masaki, K. H. Lan, F. J. Carrilho, M. Omata: YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection. In: Hepatology (Baltimore, Md.). Band 29, Nummer 3, März 1999, S. 939–945. ISSN 0270-9139, doi:10.1002/hep.510290340. PMID 10051501.
T. Shaw, S. S. Mok, S. A. Locarnini: Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. In: Hepatology (Baltimore, Md.). Band 24, Nummer 5, November 1996, S. 996–1002. ISSN 0270-9139, doi:10.1002/hep.510240504, PMID 8903366.
L. J. Scott, H. L. Chan: Tenofovir Alafenamide: A Review in Chronic Hepatitis B. In: Drugs. Band 77, Nummer 9, Juni 2017, S. 1017–1028, doi:10.1007/s40265-017-0754-9, PMID 28493172.
Y. Pei, C. Wang, S. F. Yan, G. Liu: Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection. In: Journal of medicinal chemistry. Band 60, Nummer 15, August 2017, S. 6461–6479, doi:10.1021/acs.jmedchem.6b01442, PMID 28383274.

S. K. Ono-Nita, N. Kato, Y. Shiratori, T. Masaki, K. H. Lan, F. J. Carrilho, M. Omata: YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection. In: Hepatology (Baltimore, Md.). Band 29, Nummer 3, März 1999, S. 939–945. ISSN 0270-9139, doi:10.1002/hep.510290340. PMID 10051501.
T. Shaw, S. S. Mok, S. A. Locarnini: Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. In: Hepatology (Baltimore, Md.). Band 24, Nummer 5, November 1996, S. 996–1002. ISSN 0270-9139, doi:10.1002/hep.510240504, PMID 8903366.
L. J. Scott, H. L. Chan: Tenofovir Alafenamide: A Review in Chronic Hepatitis B. In: Drugs. Band 77, Nummer 9, Juni 2017, S. 1017–1028, doi:10.1007/s40265-017-0754-9, PMID 28493172.
Y. Pei, C. Wang, S. F. Yan, G. Liu: Past, Current, and Future Developments of Therapeutic Agents for Treatment of Chronic Hepatitis B Virus Infection. In: Journal of medicinal chemistry. Band 60, Nummer 15, August 2017, S. 6461–6479, doi:10.1021/acs.jmedchem.6b01442, PMID 28383274.

S. K. Ono-Nita, N. Kato, Y. Shiratori, T. Masaki, K. H. Lan, F. J. Carrilho, M. Omata: YMDD motif in hepatitis B virus DNA polymerase influences on replication and lamivudine resistance: A study by in vitro full-length viral DNA transfection. In: Hepatology (Baltimore, Md.). Band 29, Nummer 3, März 1999, S. 939–945. ISSN 0270-9139, doi:10.1002/hep.510290340. PMID 10051501.
T. Shaw, S. S. Mok, S. A. Locarnini: Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. In: Hepatology (Baltimore, Md.). Band 24, Nummer 5, November 1996, S. 996–1002. ISSN 0270-9139, doi:10.1002/hep.510240504, PMID 8903366.